OQROGet OQRO Pro
Insider trade

Maplight Therapeutics (MPLT)CFO sold ~$22K

Jonathan Gillis, CFO at Maplight Therapeutics, sold ~$22K of Maplight Therapeutics shares.

~$22K
Approx. value · 600 sh @ $36.51
162K
Holds after · shares reported
Traded
Jul 17, 2026
Filed
Jul 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 18, 2026Insider · 1 personInsiders: 2 sales (~$3.2M)
  2. Jun 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 18, 2026, Vishwas Setia was separated as the Chief Financial Officer of MapLight Therapeutics, Inc. (the “Company”), effective immediately, following a review of a human resources violation.”
  3. Jul 15, 2026Insider · 6 peopleInsiders: 18 sales (~$4.6M)
  4. Jul 16, 2026Insider · 6 peopleInsiders: 16 sales (~$4.4M)
  5. Jul 17, 2026 · this disclosureInsiderCFO sold ~$22K of MPLT shares in the open market

What came next

  1. Jul 17, 2026Insider · 6 peopleInsiders: 9 sales (~$2.2M)
  2. Jul 28, 2026Insider · 2 peopleInsiders: 3 purchases (~$2.4M)
  3. Jul 29, 2026Insider10% owner purchased ~$38K of MPLT shares in the open market
  4. Jul 30, 2026Insider · 14 days before results10% owner purchased ~$13M of MPLT shares in the open market
  5. Aug 3, 2026InsiderOfficer sold ~$277K of MPLT shares in the open market
  6. Aug 13, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
  7. Aug 14, 2026Insider10% owner purchased ~$50.1M of MPLT shares in the open market
  8. Sep 16, 2026InsiderOfficer sold ~$193K of MPLT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Maplight Therapeutics

For Maplight Therapeutics, OQRO holds 52 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MPLT page.

Other recent filings by Jonathan Gillis, CAO and Interim CFO

The full history of Jonathan Gillis, CAO and Interim CFO is on the profile page.

How this filing works

Other disclosures at Maplight Therapeutics

Everything OQRO holds on this company is on its MPLT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data